Compounded semaglutide — 7 proven safety facts.
Compounded semaglutide is advertised online as a cheaper version of Wegovy and Ozempic. It became widely used in the US during the semaglutide shortage, and similar products now appear on UK and European websites.
This guide explains what compounded semaglutide is, whether it is legal in the UK, how the US, Australia and Europe have responded, the real risks, and the safe licensed alternatives you can use instead.
Skip the risks of unlicensed semaglutide. See pricing for genuine Wegovy at every dose.
Explore Wegovy →Compounded semaglutide: what it is
Compounded semaglutide is semaglutide mixed by a pharmacy or manufacturer outside the normal licensing system. It is not made by Novo Nordisk and has not been approved as Wegovy, Ozempic or Rybelsus.
Compounding is a legitimate practice for special cases, such as a patient who needs a liquid form of a medicine they cannot swallow. The problems start when compounding is used to mass-produce cheaper copies of a licensed medicine.
A compounded product has not been tested in clinical trials. Regulators have not checked its strength, purity or sterility.
7 proven safety facts at a glance
- Compounded semaglutide is not a licensed medicine in the UK
- UK pharmacies may only compound for an individual patient’s special need
- The US ended routine compounding after the shortage ended in February 2025
- Australia banned semaglutide compounding in October 2024
- Some products use semaglutide salts, which are not the approved ingredient
- Dosing errors with vials have sent people to hospital
- Licensed Wegovy, Ozempic and the Wegovy pill are the safe options
Why people buy it
Price is the main reason people look for compounded semaglutide. Licensed Wegovy is a monthly cost that adds up, and cheaper offers online can be tempting.
Some people also turned to compounded semaglutide when licensed pens were hard to find during supply shortages. Others are drawn by claims of extras, such as added vitamin B12, or by needle-free forms like drops.
These reasons are understandable. The trouble is that compounded semaglutide offers no proof that the product is what it claims to be.
Does compounded semaglutide work?
Some compounded semaglutide may contain the right amount of the right ingredient and work as expected. The problem is that you cannot know which products do.
The weight loss seen in trials such as STEP-1, around 15% on average, comes from licensed semaglutide made to strict standards. Those results cannot simply be applied to compounded semaglutide.
If a product contains less semaglutide than labelled, you may see little effect. If it contains more, side effects can be severe. See our Wegovy weight loss results guide for what licensed treatment achieves.
Added B12 and other extras
Some compounded semaglutide products are sold with added vitamin B12, glycine or other extras. Sellers claim these reduce side effects or boost energy.
There is no good evidence that these additions improve results. They also mean the product is even further from the licensed medicine that was tested in trials.
If you are low in vitamin B12, your GP can test for this and treat it separately.
Storage and handling
Licensed semaglutide pens are made, shipped and stored under strict temperature controls. Compounded semaglutide may be posted without proper cooling, which can damage the medicine.
Vials also need to be mixed or drawn up by hand, raising the risk of contamination. Our how to store GLP-1 peptides guide explains why temperature matters.
Questions to ask any provider
- Is this product licensed by the MHRA?
- Which brand is it, and who makes it?
- Are you registered with the General Pharmaceutical Council?
- Will a prescriber review my medical history?
- Who can I contact if I have side effects?
A legitimate UK provider will answer all of these clearly. If they cannot, or if they are selling compounded semaglutide to the public, look elsewhere.
Is it legal in the UK?
In the UK, a medicine needs a marketing authorisation from the MHRA before it can be sold. Wegovy, Ozempic, Rybelsus and the Wegovy pill have this licence.
Pharmacies can prepare unlicensed medicines, sometimes called specials, but only when a prescriber judges that an individual patient has a clinical need that licensed products cannot meet. Cost or convenience is not a valid reason.
Mass-produced compounded semaglutide sold as a cheaper Wegovy is therefore not allowed. In 2026, an unlicensed sublingual semaglutide was marketed to private UK doctors, and Novo Nordisk warned that mass compounding poses a significant risk to patient safety.
Websites selling vials, powders or “semaglutide drops” to the public in the UK are selling unlicensed products.
Why it took off in the US
Most of the talk about compounded semaglutide comes from the United States. During a national shortage of Wegovy and Ozempic, US rules allowed pharmacies to make copies.
Telehealth companies sold compounded semaglutide at much lower prices, and millions of people used them. The FDA declared the semaglutide shortage over in February 2025, and pharmacies were given until spring 2025 to stop making routine copies.
| Date | US event |
|---|---|
| 2022–2024 | Semaglutide shortage allows compounding |
| February 2025 | FDA declares the shortage resolved |
| April–May 2025 | Deadlines for pharmacies to stop routine compounding |
| September 2025 | Warning letters over misleading marketing |
| March 2026 | 30 warning letters to telehealth firms marketing compounded GLP-1s |
In 2026, the FDA said compounders should not try to get around its approval process by mass-marketing compounded drugs.
Australia and Europe
Australia
Australia banned pharmacists from compounding semaglutide and other GLP-1 medicines from October 2024. The government cited patient safety fears after around 20,000 people had been using compounded versions.
Europe
Across the EU, semaglutide must also be a licensed product. The European Medicines Agency has warned about falsified Ozempic pens, and national regulators have taken action against illegal online sellers.
Rules on pharmacy-prepared medicines vary by country, but none allow mass-produced compounded semaglutide as a copy of Wegovy. For licensed prices across Europe, see our semaglutide price Europe guide.
The real risks of unlicensed copies
Because compounded semaglutide skips the licensing process, several things can go wrong.
- Wrong strength: products may contain more or less semaglutide than the label says
- Contamination: injections made in unregulated conditions may not be sterile
- Different ingredients: some products use semaglutide salts or added vitamins
- Dosing errors: vials and syringes make it easy to measure the wrong amount
- No trial data: nobody knows how these exact products perform
The FDA has received reports of people needing hospital care after using compounded semaglutide, often after measuring doses wrongly from vials. Some took five to twenty times the intended dose because of confusion between units and millilitres.
The problem with semaglutide salts
Some compounded semaglutide products have used forms such as semaglutide sodium or semaglutide acetate. These are different chemical forms from the semaglutide in Wegovy and Ozempic.
The FDA has said these salt forms are not the approved active ingredient and should not be used in compounding. Their safety and effectiveness have not been shown.
A product label that simply says “semaglutide” does not tell you which form or what purity it contains.
Fake pens and illegal sellers
Compounded semaglutide is not the only unlicensed supply. Criminals have relabelled insulin pens as Ozempic, sold semaglutide powder for home mixing and sold pre-mixed syringes.
In the UK, people have been hospitalised after using fake Ozempic pens. Their symptoms, including dangerously low blood sugar, suggested the pens contained insulin.
The MHRA has seized hundreds of fake weight loss pens and shuts down thousands of illegal medicine websites each year. If a deal looks too good to be true, it usually is.
Compounded vs generic vs licensed
These three terms are often mixed up. The table shows how they differ.
| Type | Licensed in the UK? | Clinical trials | Quality checked by a regulator |
|---|---|---|---|
| Wegovy / Ozempic / Wegovy pill | Yes | Yes, full trials | Yes |
| Approved generic semaglutide | Not yet (around 2031) | Relies on original data | Yes, where approved |
| Compounded semaglutide | No | No | No |
| Research-use-only semaglutide | No | No | No |
Read our generic semaglutide guide to see where licensed copies are already sold.
Research-use-only products
Some websites sell semaglutide labelled “for research use only”. This is a chemical, not a medicine, and it is not intended for people to inject.
Like compounded semaglutide, these products are unlicensed, and they avoid medicine laws by claiming to be for laboratories. Our research peptides UK legal guide explains the legal position, and our peptides for weight loss UK guide covers the wider market.
How to spot unlicensed semaglutide
- It is sold as a vial, powder, drops or unbranded pen
- No medical consultation is needed before you buy
- The seller is not registered with the General Pharmaceutical Council
- It is labelled “research use only” or “not for human consumption”
- The price is far below any licensed UK provider
- There is no UK patient information leaflet
A genuine UK supply comes as a branded Wegovy or Ozempic pen, or the Wegovy pill, in sealed packaging. It is always prescribed after a consultation.
Is it really cheaper?
Compounded semaglutide is often advertised far below the price of Wegovy. That saving comes at the cost of every safety check.
In the UK, licensed Wegovy currently costs from about £90–£150 a month at 0.25mg and £186–£305 at 2.4mg, depending on the provider. Shopping around between registered pharmacies is the safest way to save.
- Compare several GPhC-registered providers
- Ask about lower maintenance doses
- Consider the Wegovy pill as a daily alternative
- Check NHS eligibility through your GP
- Use payment plans where offered
See our Wegovy pill UK price and availability guide or explore the Wegovy pill.
Licensed options compared
Instead of compounded semaglutide, these licensed options are available through UK prescribers.
| Option | Form | Licensed for | Typical maintenance dose |
|---|---|---|---|
| Wegovy | Weekly injection | Weight management | 2.4mg (7.2mg higher dose) |
| Wegovy pill | Daily tablet | Weight management | 25mg |
| Ozempic | Weekly injection | Type 2 diabetes | 0.5mg–2mg |
| Mounjaro | Weekly injection | Weight management and type 2 diabetes | 5mg–15mg |
Each of these has full trial data and an MHRA licence, unlike compounded semaglutide. Compare the two leading choices in our Wegovy vs Mounjaro guide.
If you have already used it
If you have been using compounded semaglutide, don’t panic. Speak to a doctor or pharmacist about switching to a licensed brand.
Your prescriber will usually restart you at a low dose, because you cannot be sure how much semaglutide you were really taking. Our semaglutide dosage chart explains each licensed step.
Report any side effects or suspected fake products through the MHRA Yellow Card scheme. This helps protect other people.
Keep any leftover compounded semaglutide and its packaging until you have spoken to a professional. Details such as the seller, batch number and label can help regulators trace where it came from.
Once you switch, your prescriber can track your progress properly, adjust doses safely and support you with side effects. Many people find the move to a licensed pen reassuring rather than disruptive.
Side effects to watch for
Licensed semaglutide commonly causes nausea, diarrhoea, constipation and reduced appetite, especially after dose increases. With compounded semaglutide, these can be stronger if the dose is wrong.
- Severe or ongoing vomiting
- Strong stomach pain that spreads to your back
- Signs of very low blood sugar, such as shaking, sweating or confusion
- Redness, swelling or heat around an injection site
Get urgent medical help if you notice any of these. Our Wegovy side effects guide covers what is normal on licensed treatment.
What about compounded tirzepatide?
The same problems apply to compounded tirzepatide sold as a cheaper Mounjaro. It is not licensed in the UK, and the FDA has taken similar action against it in the US.
Read our tirzepatide UK guide for the licensed options, or compare the two medicines in semaglutide vs tirzepatide.
How compounding grew so fast
Demand for semaglutide rose far faster than supply in 2022 and 2023. Licensed pens were hard to find, and many people stayed on waiting lists for months.
In the US, shortage rules let pharmacies fill the gap, and online clinics built entire businesses around cheaper copies. Social media advertising then spread interest to the UK and Europe.
Many buyers did not realise they were using an unlicensed product. Websites often used medical language, doctor photos and before-and-after pictures that made compounded semaglutide look like a standard prescription.
Once licensed supply recovered, regulators moved to close the gap. The rules that once allowed mass production no longer applied, but many sellers kept marketing their products online.
How UK regulators respond
The MHRA works with Border Force, the police and online platforms to take down illegal medicine sellers. It also issues warnings when fake or unlicensed weight loss products are found.
- Seizing illegal weight loss pens and vials at the border
- Shutting down websites and social media accounts selling medicines
- Investigating sellers who supply prescription medicines without a prescription
- Collecting reports from patients through the Yellow Card scheme
The General Pharmaceutical Council also regulates online pharmacies. Any UK pharmacy supplying compounded semaglutide to the public as a cheaper Wegovy risks action from both bodies.
Key takeaways
- Compounded semaglutide is not a licensed medicine in the UK
- The US and Australia have both clamped down on compounding
- Products may have the wrong strength, salts or contamination
- Fake pens have contained insulin and caused hospital admissions
- Licensed Wegovy, Ozempic and the Wegovy pill are the safe choices
Ready to start with a licensed brand? Our Wegovy product page shows pricing at every dose, and our semaglutide UK guide compares every brand.
A cheaper price means nothing if you cannot trust what is in the pen.
Mymetabolism TeamCommon questions — Compounded Semaglutide
Explore Wegovy with Mymetabolism.
Genuine licensed semaglutide at every dose, with transparent UK pricing and support.
Explore Wegovy →